Oct 15,2018

Senseonics Holdings, Inc. Schedules Third Quarter 2018 Earnings Release and Conference Call for November 8, 2018 at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it plans to release its third quarter 2018 financial results after market close on Thursday, November 8, 2018.

View Analyst & Ambassador Comments
Go to original news
Oct 16,2018

One Drop Recognized as Top-3 Digital Diabetes Care Provider Worldwide

One Drop has been recognized as a top global digital diabetes care provider in terms of diabetes app portfolio, service offerings, performance, and strategy. In just one year, the company increased its market share to 6.3% of the global market, ranking #3 for downloads worldwide. Among the 2,000+ diabetes apps evaluated in Research2Guidance's 2018 Digital Diabetes Care Market report, the definitive industry overview on current and future trends for mobile app-based digital diabetes care, One Drop stands out as an international product with the highest availability rate in 4 countries, beating out Roche's mySugr (3 countries), Lifescan's OneTouch (2 countries), and other popular apps.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Oct 17,2018

Tandem Diabetes Care to Announce Third Quarter 2018 Financial Results on November 1, 2018

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, plans to release its third quarter 2018 results after the financial markets close on Thursday, November 1, 2018. The Company will hold a conference call and simultaneous webcast on the same day at 5:30pm Eastern Time (2:30pm Pacific Time), to discuss its third quarter 2018 financial and operating results.

View Analyst & Ambassador Comments
Go to original news
Oct 18,2018

DarioHealth Appoints Glen D. Moller, Healthcare Executive, Investor and Former CEO of ArroHealth, to Its Board of Directors

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Glen Moller has joined the Company's Board of Directors.

View Analyst & Ambassador Comments
Go to original news
Oct 22,2018

Senseonics Announces Aetna’s Positive Coverage Decision for Eversense

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that Aetna, the third largest commercial health plan provider in the United States, is providing coverage for Eversense, effective immediately.

COLLABORATION PARTNERSHIP

#insurance

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 22,2018

Nemaura to Host Investor Webinar on October 23rd 2018 to Provide Update on Recent Developments

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes and pre-diabetics, will host an investor webinar and live Q&A session on Tuesday, October 23, at 11:00 a.m. EST. The webinar will feature a presentation by Dr. Faz Chowdhury, CEO of Nemaura, who will discuss recent developments, key benefits of sugarBEAT® over existing competition, target markets, and plans for the commercial launch of sugarBEAT®, as well as key upcoming milestones.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Oct 23,2018

DarioHealth's Digital Health Blood Glucose Monitoring System Compatible With New iPhone XS and XS Max

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that its Dario LC™ Blood Glucose Monitoring System, which enables the use of the Dario App, is compatible with the iPhone XS and iPhone XS Max, both of which were launched on September 21, 2018.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 25,2018

Jan Berger, MD, and Roberta Herman, MD, join Voluntis’ Board of Directors

Voluntis (Euronext Paris, ticker: VTX – ISIN: FR0004183960), a digital therapeutics company, announced today the nominations of Jan Berger, MD, and Roberta Herman, MD, to its Board of Directors. Dr. Herman and Dr. Berger are both healthcare industry veterans with special expertise in US payers and providers.

View Analyst & Ambassador Comments
Go to original news
Oct 25,2018

DarioHealth Launches Integrated Diabetes Digital Health Solution Including Version 4.1 of Its Dario App and DarioEngage Patient Coaching Platform

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today the launch of version 4.1 of its award-winning Dario® App for the Dario Blood Glucose Monitoring System, part of the DarioHealth digital diabetes data management platform. The app, which is available both direct-to-consumer and through healthcare providers, is now fully integrated with the DarioEngage patient management and coaching platform, which serves the healthcare provider market.

PRODUCT

#bgm

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 28,2018

myDiabby Healthcare opens its platform to pediatric diabetology

Since October 2018, myDiabby has opened its platform to monitoring children with diabetes. Launched in April 2015 initially for the follow-up of gestational diabetes then extended in 2017 to type 1 and 2 diabetes, myDiabby's mission is to connect people with diabetes to their usual medical team.

PRODUCT

#telehealth

#rpm

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES